Johnson & Johnson (NYSE: JNJ) reported its third quarter 2025 earnings results today. Reported sales increased 6.8% year-over-year to $24 billion. Operational
Johnson & Johnson
-(JNJ)
XNYS:JNJ
Innovation pipeline, portfolio in focus ahead of Johnson & Johnson’s Q3 earnings
For Johnson & Johnson (NYSE: JNJ), 2025 has been a strong year, marked by an impressive financial performance that drove the stock
Key highlights from Johnson & Johnson’s (JNJ) Q2 2025 earnings results
Johnson & Johnson (NYSE: JNJ) reported its second quarter 2025 earnings results today. Reported sales increased 5.8% year-over-year to $23.7 billion. Operational
Johnson & Johnson to report Q2 earnings on July 16. Here’s what to expect
Johnson & Johnson's (NYSE: JNJ) business strategy for fiscal 2025 is focused on reducing the impact of patent expirations on its revenue.
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2025 financial results
Johnson & Johnson (NYSE: JNJ) reported its first quarter 2025 earnings results today. Reported sales increased 2.4% year-over-year to $21.9 billion. Operational
Deals and R&D in focus as Johnson & Johnson gears up for Q1 earnings
For Johnson & Johnson (NYSE: JNJ), investments in its pipeline and exiting lower priority businesses remain central to its strategy in the
JNJ Earnings: All you need to know about Johnson & Johnson’s Q4 2024 earnings results
Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2024 earnings results today. Reported sales increased 5.3% year-over-year to $22.5 billion. Operational
Johnson & Johnson (JNJ) likely to report mixed results for Q4 2024
Johnson & Johnson (NYSE: JNJ) is set to publish its December-quarter report on January 22, amid expectations for mixed results. The company,
Johnson & Johnson (JNJ) Q3 2024 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported its third quarter 2024 earnings results today. Reported sales increased 5.2% year-over-year to $22.5 billion. GAAP earnings
Earnings Preview: Johnson & Johnson bets on innovation to stay in growth mode
Over the years, Johnson & Johnson (NYSE: JNJ) has remained a dominant player in the medical industry, benefitting from its unique business
Johnson & Johnson (JNJ) Q2 2024 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported its second quarter 2024 earnings results today. Reported sales increased 4.3% year-over-year to $22.4 billion. Operational sales
Johnson & Johnson to publish Q2 report next week. Here’s what to look for
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) has constantly strengthened its portfolio over the years by acquiring new businesses, investing in new
Key takeaways from Johnson & Johnson’s (JNJ) Q1 2024 earnings report
Over the years, Johnson & Johnson (NYSE: JNJ) has constantly ramped up its portfolio and pipeline. After spinning off the consumer health
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2024 financial results
Johnson & Johnson (NYSE: JNJ) reported first quarter 2024 earnings results today. Reported sales increased 2.3% year-over-year to $21.4 billion. The company
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q4 2023 financial results
Johnson & Johnson (NYSE: JNJ) reported fourth quarter 2023 earnings results today. Reported sales increased 7.3% year-over-year to $21.4 billion. Net earnings
Johnson & Johnson (JNJ) set to report Q4 earnings. Here’s what to expect
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) will be publishing fourth-quarter results next week. Over the years, the company has enjoyed an
Johnson & Johnson (JNJ) focuses on innovation after separating consumer business
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently raised its full-year guidance to reflect the strong performance of the pharmaceutical and medical
JNJ Earnings: All you need to know about Johnson & Johnson’s Q3 2023 earnings results
Johnson & Johnson (NYSE: JNJ) reported third quarter 2023 earnings results today. Reported sales increased 6.8% year-over-year to $21.3 billion. Operational sales
Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q3 2023 Earnings Call dated Oct. 17, 2023 Corporate Participants: Jessica Moore -- Vice President - Investor
Johnson & Johnson to report earnings on Oct 17. Here’s what to look for
After reporting better-than-expected quarterly earnings consistently for over a decade, healthcare behemoth Johnson & Johnson (NYSE: JNJ) is preparing to release its
Johnson & Johnson (JNJ) Q2 2023 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported second quarter 2023 earnings results today. Reported sales increased 6.3% year-over-year to $25.5 billion. GAAP net